Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Gene Polymorphisms and Vincristine-Induced Neuropathy in Patients Who Received R-CHOP Chemotherapy

Akihiko Sawaki, MD, Kana Miyazaki, MD PhD, Toshifumi Takeuchi, MD PhD, Kyoko Kobayashi, MD PhD, Hiroshi Imai, MD PhD, Isao Tawara, MD PhD, Ryoichi Ono, MD PhD, Tetsuya Nosaka, MD PhD, Motoko Yamaguchi, MD PhD, Naoyuki Katayama, MD PhD

Blood (2019) 134 (Supplement_1): 1624.

https://doi.org/10.1182/blood-2019-122796

Published: 2019

Journal Articles

Cell of Origin Classification of DLBCL Using Targeted NGS Expression Profiling and Deep Learning

Blood (2019) 134 (Supplement_1): 2891.

https://doi.org/10.1182/blood-2019-126927

Published: 2019

Journal Articles

Distinct Chromatin Accessibility Changes, Aberrant Transcription Factor Networks Combined with Novel Oncogenic Enhancers Characterise Myeloma-Initiating Genetic Events

Nikolaos Trasanidis, Jaime Alvarez-Benayas, Alexia Katsarou, Aristeidis Chaidos, Philippa C May, Kanagaraju Ponnusamy, Xiaolin Xiao, Marco Bua, MD, Maria Atta, MD, Irene Roberts, Holger W Auner, MD PhD, Evdoxia Hatjiharissi, Maria Papaioannou, Valentina S Caputo, Ian Sudbery, Anastasios Karadimitris

Blood (2019) 134 (Supplement_1): 1769.

https://doi.org/10.1182/blood-2019-124761

Published: 2019

Journal Articles

Potential Familial Predisposition to Hematologic Neoplasm Detected Incidentally in Adult Patients Presenting with Myeloid Neoplasms

Vincent Funari, PhD, Maya Thangavelu, PhD, Wanlong Ma, MS, Ivan De Dios, BS, Sally Agersborg, MD PhD, Forrest Blocker, PhD, Maher Albitar, MD

Blood (2017) 130 (Supplement 1): 585.

https://doi.org/10.1182/blood.V130.Suppl_1.585.585

Published: 2017

Journal Articles

MDS Diagnosis Using cfRNA Profiling By Targeted Enrichment Next Generation Sequencing

Cynthie Wong, PhD, Vincent Funari, PhD, Wanlong Ma, MS, Ivan De Dios, BS, Forrest Blocker, PhD, Babak Shahbaba, PhD, Maher Albitar, MD

Blood (2017) 130 (Supplement 1): 4268.

https://doi.org/10.1182/blood.V130.Suppl_1.4268.4268

Published: 2017

Journal Articles

Clonal Hematopoiesis in Normal Individuals Is Not Random and Likely Reflects Early MDS

Wanlong Ma, MS, Ivan De Dios, BS, Vincent Funari, PhD, Sucha Sudarsanam, MS, Shi-Ping Jiang, MD, Sally Agersborg, MD PhD, Jennifer Hummel, MD MPH, Forrest Blocker, PhD, Maher Albitar, MD

Blood (2017) 130 (Supplement 1): 4269.

https://doi.org/10.1182/blood.V130.Suppl_1.4269.4269

Published: 2017

Journal Articles

Liquid Biopsy As a Diagnostic Test for Myelodysplastic Syndrome and Other Acute and Chronic Myeloid Neoplasms

Wanlong Ma, MS, Ivan De Dios, BS, Vincent Funari, PhD, Shi-Ping Jiang, MD, Sally Agersborg, MD PhD, Jennifer Hummel, MD MPH, Forrest Blocker, PhD, Maher Albitar, MD

Blood (2017) 130 (Supplement 1): 4270.

https://doi.org/10.1182/blood.V130.Suppl_1.4270.4270

Published: 2017

Journal Articles

FLT3 Mutation in Acute Myeloid Leukemia: Primary or Secondary Mutation?

Wanlong Ma, MS, Ivan De Dios, BS, Vincent Funari, PhD, Sucha Sudarsanam, MS, Shi-Ping Jiang, MD, Sally Agersborg, MD PhD, Jennifer Hummel, MD MPH, Forrest Blocker, PhD, Maher Albitar, MD

Blood (2017) 130 (Supplement 1): 2668.

https://doi.org/10.1182/blood.V130.Suppl_1.2668.2668

Published: 2017

Journal Articles

Using Targeted Enrichment RNA Sequencing in the Diagnosis of Hematologic Neoplasms in Fresh and Paraffin-Embedded Tissue

Wanlong Ma, MS, Ivan De Dios, BS, Vincent Funari, PhD, Babak Shahbaba, PhD, Forrest Blocker, PhD, Maher Albitar, MD

Blood (2017) 130 (Supplement 1): 5118.

https://doi.org/10.1182/blood.V130.Suppl_1.5118.5118

Published: 2017

Journal Articles

IDH1 and IDH2 : Founding or Progressor Mutations in Myeloid Neoplasms

Wanlong Ma, MS, Ivan De Dios, BS, Vincent Funari, PhD, Sucha Sudarsanam, MS, Shi-Ping Jiang, MD, Sally Agersborg, MD PhD, Jennifer Hummel, MD MPH, Forrest Blocker, PhD, Maher Albitar, MD

Blood (2017) 130 (Supplement 1): 405.

https://doi.org/10.1182/blood.V130.Suppl_1.405.405

Published: 2017

Journal Articles

Interclonal and Intraclonal Heterogeneity in Patients with IDH1/2 Mutation

Wanlong Ma, BS, Maya Thangavelu, PhD, Ivan De Dios, BS, Vincent Funari, PhD, Maher Albitar, MD

Blood (2016) 128 (22): 1689.

https://doi.org/10.1182/blood.V128.22.1689.1689

Published: 2016

Journal Articles

Higher Mutation Rate in Patients with Aplastic Anemia Using Peripheral Blood cfDNA As Compared with Bone Marrow Cells

Adam Albitar, BS, Danielle Townsley, MD, Wanlong Ma, BS, Ivan De Dios, BS, Vincent Funari, PhD, Neal S. Young, Maher Albitar, MD

Blood (2016) 128 (22): 3902.

https://doi.org/10.1182/blood.V128.22.3902.3902

Published: 2016

Journal Articles

MYD88, CD79B, and CD79A Gene Mutations in CD5-Positive Diffuse Large B-Cell Lymphoma

Toshifumi Takeuchi, MD, Motoko Yamaguchi, MD PhD, Kyoko Kobayashi, MD PhD, Kana Miyazaki, MD PhD, Hiroshi Imai, MD PhD, Ryoichi Ono, MD PhD, Isao Tawara, MD PhD, Tetsuya Nosaka, MD PhD, Kyosuke Tanaka, MD PhD, Naoyuki Katayama, MD PhD

Blood (2016) 128 (22): 1861.

https://doi.org/10.1182/blood.V128.22.1861.1861

Published: 2016

Journal Articles

Using Next Generation Sequencing of Peripheral Blood cfDNA As a Clinical Test in Screening for Hematologic Neoplasms

Vincent Funari, PhD, Wanlong Ma, BS, Maya Thangavelu, PhD, Ivan De Dios, BS, Maher Albitar, MD

Blood (2016) 128 (22): 3176.

https://doi.org/10.1182/blood.V128.22.3176.3176

Published: 2016

Journal Articles

Expression of LMO3 and SNAP25 in Diffuse Large B-Cell Lymphoma Cells and Its Relation to Clinical Features

Kyoko Kobayashi, MD, Motoko Yamaguchi, MD PhD, Kana Miyazaki, MD PhD, Hiroshi Imai, MD PhD, Kaori Yokoe, Ryoichi Ono, MD PhD, Tetsuya Nosaka, MD PhD, Naoyuki Katayama, MD PhD

Blood (2014) 124 (21): 2985.

https://doi.org/10.1182/blood.V124.21.2985.2985

Published: 2014

Journal Articles

A Retrospective Cohort Study of Interferon-α Therapy in Myeloproliferative Neoplasms; Adverse Events, Thromboembolic Incidence and Causes of Termination of Therapy

Marie Lindgren, MD, Jan Samuelsson, MD PhD, Lars Nilsson, MD PhD, Håvar Knutsen, MD, Waleed Ghanima, MDPhD, Maria Åström, MD PhD, Elisabeth Ejerblad, MD, Anna Hugosson, MD, Peter L. Johansson, MD PhD, Björn Andréasson, MD PhD

Blood (2014) 124 (21): 1861.

https://doi.org/10.1182/blood.V124.21.1861.1861

Published: 2014

Journal Articles

Multidimensional Flow Cytometric (MFC) Analysis of the Immune System of Multiple Myeloma (MM) Patients Achieving Long Term Disease Control

Roberto J. Pessoa Magalhaes, María-Belén Vidriales, Bruno Paiva, Maria-Victoria Mateos, Norma C. Gutierrez, Ramón García-Sanz, Juan F Blanco, Jose Hernández, Natalia de las Heras, Joaquin Martinez, MD, Elaine Sobral Costa, MD, PhD, Angelo Maiolino, MD, PhD, M. Nucci, MD, PhD, Javier De La Rubia, Juan-Jose Lahuerta, MD, Alberto Orfao, MD, PhD, Jesús F. San Miguel, Sr., MD, PhD

Blood (2011) 118 (21): 810.

https://doi.org/10.1182/blood.V118.21.810.810

Published: 2011

Journal Articles

Two-Stage Pharmacokinetic & Efficacy Study of Lenalidomide Alone or Combined with Recombinant Erythropoietin (EPO) in Lower Risk MDS EPO-Failures [PK-002].

Alan F. List, MD, Jeffrey E. Lancet, MD, Magda Melchert, MD, Hussein Saba, MD, Richard Lush, PhD, Jian Yu, PhD, Nianhang Chen, PhD, Michele Schmidt, RN, Robert Knight, MD

Blood (2007) 110 (11): 4626.

https://doi.org/10.1182/blood.V110.11.4626.4626

Published: 2007

Journal Articles

Plasma Levels of High Mobility Group Box Protein in Patients with Organ Failure, Disseminated Intravascular Coagulation or Poor Outcome.

Hideo Wada, MD, PhD, Tsutomu Nobori, MDPhD, Shingo Yamada, PhD, Ikuro Maruyama, MDPhD

Blood (2005) 106 (11): 2142.

https://doi.org/10.1182/blood.V106.11.2142.2142

Published: 2005

Journal Articles

Lineage-Specific Transcriptional Regulation of GATA1 Is Dependent on Lineage-Specific Utilisation of Multiple Cis-Elements and Haematopoietic Transcription Factors.

Paresh Vyas, MD PhD, Boris Guyot, PhD, Veronica Valverde-Garduno, PhD, Eduardo Anguita, MD PhD, Isla Hamlett, BSc, Catherine Porcher, PhD

Blood (2004) 104 (11): 1610.

https://doi.org/10.1182/blood.V104.11.1610.1610

Published: 2004

NARROW

Gene Polymorphisms and Vincristine-Induced Neuropathy in Patients Who Received R-CHOP Chemotherapy

Cell of Origin Classification of DLBCL Using Targeted NGS Expression Profiling and Deep Learning

Distinct Chromatin Accessibility Changes, Aberrant Transcription Factor Networks Combined with Novel Oncogenic Enhancers Characterise Myeloma-Initiating Genetic Events

Potential Familial Predisposition to Hematologic Neoplasm Detected Incidentally in Adult Patients Presenting with Myeloid Neoplasms

MDS Diagnosis Using cfRNA Profiling By Targeted Enrichment Next Generation Sequencing

Clonal Hematopoiesis in Normal Individuals Is Not Random and Likely Reflects Early MDS

Liquid Biopsy As a Diagnostic Test for Myelodysplastic Syndrome and Other Acute and Chronic Myeloid Neoplasms

FLT3 Mutation in Acute Myeloid Leukemia: Primary or Secondary Mutation?

Using Targeted Enrichment RNA Sequencing in the Diagnosis of Hematologic Neoplasms in Fresh and Paraffin-Embedded Tissue

IDH1 and IDH2 : Founding or Progressor Mutations in Myeloid Neoplasms

Interclonal and Intraclonal Heterogeneity in Patients with IDH1/2 Mutation

Higher Mutation Rate in Patients with Aplastic Anemia Using Peripheral Blood cfDNA As Compared with Bone Marrow Cells

MYD88, CD79B, and CD79A Gene Mutations in CD5-Positive Diffuse Large B-Cell Lymphoma

Using Next Generation Sequencing of Peripheral Blood cfDNA As a Clinical Test in Screening for Hematologic Neoplasms

Expression of LMO3 and SNAP25 in Diffuse Large B-Cell Lymphoma Cells and Its Relation to Clinical Features

A Retrospective Cohort Study of Interferon-α Therapy in Myeloproliferative Neoplasms; Adverse Events, Thromboembolic Incidence and Causes of Termination of Therapy

Multidimensional Flow Cytometric (MFC) Analysis of the Immune System of Multiple Myeloma (MM) Patients Achieving Long Term Disease Control

Two-Stage Pharmacokinetic & Efficacy Study of Lenalidomide Alone or Combined with Recombinant Erythropoietin (EPO) in Lower Risk MDS EPO-Failures [PK-002].

Plasma Levels of High Mobility Group Box Protein in Patients with Organ Failure, Disseminated Intravascular Coagulation or Poor Outcome.

Lineage-Specific Transcriptional Regulation of GATA1 Is Dependent on Lineage-Specific Utilisation of Multiple Cis-Elements and Haematopoietic Transcription Factors.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only